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The increasing worldwide prevalence of obesity is a major health problem since excessive body weight constitutes a risk factor in
a number of chronic diseases. It has been reported that obese individuals are more susceptible to infection than lean subjects;
however, the underlying factors are not fully understood. Limited and often controversial information exists comparing
immunocompetence in obese and nonobese subjects as well as the cellular and molecular mechanisms involved, although
much evidence supports a link between adipose tissue metabolism and immunocompetent cell functions. The complexity and
heterogeneity of nutritional status and immune system interactions require an integral study of the immunocompetent cells,
their subsets and products, as well as specific and non-specific inducer=regulatory systems in situations of human obesity.
Additional research is needed to determine the clinical implications of these alterations on immunity and whether various
interventions such as weight loss, exercise or nutrient supplementation could help to ameliorate them.
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Introduction
The immune system protects the organism against patho-
gens in two major ways: innate or natural immunity (non-
specific) and acquired immunity (specific) that requires pre-
vious exposure to pathogens. Innate immunity includes
physical barriers, lysozime, complement system, mediators
of inflammation, macrophage-monocyte system, natural
killer (NK) cells and others (Marti et al, 2001). Acquired
immunity involves two different cell types: B-lymphocytes
that produce and secrete different specific immunoglobulin
subtypes (humoral immunity) and T-lymphocytes that reg-
ulate the immune response (T-helper lymphocytes; CD4þ)
and destroy tumoral and viruses-infected cells (T-cytotoxic
cells; CD8þ). These two principal branches act coordinately
in order to develop an integrated defense. Examples of this
interaction are the stimulation of T-helper cells by an anti-
gen to produce cytokines (IL-2), which promotes prolifera-
tion and differentiation of macrophages as well as the
interplay between T-helper and B-cells leading to immuno-
globulin production of B-cells.
Obesity, a disorder of energy balance in which energy
intake is greater than energy expenditure, has been linked to
a wide variety of health problems including hypertension,
dyslipidemia, cardiovascular diseases, diabetes mellitus and
certain types of cancer (Samartı´n & Chandra, 2001). In
addition, obese individuals have shown increased suscept-
ibility to infections, bacteremia and poor wound healing
following surgical procedures. Obesity has also been asso-
ciated with a poor antibody response to hepatitis B plasma
vaccine. The mechanisms responsible for the increased risk
of infection and poor antibody response among obese sub-
jects are unknown, but may be linked to the negative effect
that their metabolic milieu produces on immunity.
Another source of evidence comes from leptin, which is
mainly derived from adipocytes and regulates appetite and
energy expenditure. The leptin receptor is expressed in
several immune cell types and appears to activate a
number of cytokine-like signaling pathways. Studies in
leptin-deficient ob=ob mice have revealed impaired phagocy-
tosis and altered cytokine production, suggesting that leptin
regulates macrophage function. Adipsin, which is secreted
abundantly in adipose tissue, has complement factor D
activity and catalyzes the first activation step in the alter-
native pathway of complement. Moreover, it is known that
adipocytes produce factor D and C3 of the complement
cascade. These observations suggest a link between adipsin
and the complement alternative pathway with obesity.
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The main problem in understanding whether obesity
affects immunity is that the obese population is too hetero-
geneous in various aspects, including dietary patterns, indi-
vidual microbial and social environments. As many of the
observations in obese humans are supported by similar
results in obese animals, these models may be helpful to
examine the effects of obesity on immunity independently
of the confounding heterogeneity in the human being.
Dietary lipids and immune function
The importance of dietary lipids on immune function has
come under serious study only in the last few decades
(Calder, 1998). Dietary fat may increase the prevalence of
cancer by depressing the tumor control mechanisms of the
immune system. It appears from animal studies that obesity
and consumption of diets high in fat impair immune
response and enhance the risk for serious infectious diseases.
Dietary lipids are particularly important in maintaining
tissue concentrations of polyunsaturated fats, including lino-
leic acid that cannot be produced in the body and is required
by lymphocytes for optimal function (Ochoa et al, 2001).
Consumption of diets rich in monounsaturated fatty acids
(MUFAs) has been associated with a lower prevalence of
atherosclerosis (Yaqoob, 1998); however, less attention has
been paid to the effects of MUFAs on the immune system.
Cells of the immune system are an inherent part of the
inflammatory events involved in atherosclerosis and studies
show that a diet rich in MUFAs leads to a decrease in
intercellular adhesion molecule-1 (ICAM-1) expression, a
protein involved in leukocyte – leukocyte adhesion as well
as leukocyte – endothelial cell adhesion. Also, it seems that
MUFAs decrease the expression of another related protein,
the primary fibrinogen receptor in leukocytes (Mac-1), which
may play a role in the pathophysiology of inflammation. In
contrast, MUFAs appear not to influence NK cell activity or
the proliferative response of T-lymphocytes.
However, several studies have reported lower T-lympho-
cyte proliferation and decreased cytotoxic T-lymphocyte
activity after feeding a high-fat rich diet in n-6 PUFAs
(Calder, 1998). NK cell cytotoxic activity has also been
found to be lower. An inverse linear correlation has been
reported between the level of oleic acid or the oleic acid:
linoleic acid ratio and spleen cytotoxic NK cell activity.
Moreover, it has been shown that n-6 PUFAs intake reduces
IL-2 production and IFN-g.
Diets rich in n-3 PUFAs have been related to the inhibi-
tion of cell-mediated immune responses, but the mechan-
isms are still unclear (Ochoa et al, 2001). It has been
postulated that n-3 PUFAs may inhibit the function of
human antigen-presenting cells implicated in the recogni-
tion of antigens. This is supported by the findings that diets
rich in n-3 PUFAs have lower capacity to present antigens to
autologous lymphocytes related to a diminished expression
of surface adhesion molecules. Interestingly, these data sug-
gest a potential mechanism for the beneficial effect of n-3
PUFAs in the treatment of rheumatoid arthritis, an autoim-
mune alteration associated with elevated expression of MHC
class II and adhesion molecules on antigen-presenting cells.
Furthermore, diets rich in n-3 PUFAs have been reported to
produce higher serum concentrations of IFN-g during Listeria
monocytogenes infection. IFN-g positively regulates inducible
nitric oxide synthase (iNOS), to enable macrophage-
mediated killing of intracellular pathogens, and potentiate
the expression of class I and II MHC molecules to facilitate
the specific immune response.
Obese animal models and immune function
Different animal models are used to analyse how obesity
influences the immune status: genetically obese rodents
characterised by mutations in the leptin gene (ob=ob mice)
or leptin receptor gene (db=db mice and fa=fa rats) and diet-
induced obese rodents. These animals presented T-lympho-
penia in all subsets and B-cell population is also diminished
(Kimura et al, 1998). Lymphocyte responsiveness to different
mitogens is lower in obese animals compared with lean ones.
Obese animals also produce less IL-2 than lean animals
which could partly explain the lower capacity of T cells to
proliferate in obese animals (Tanaka et al, 1998). Elevated
serum free fatty acid concentrations may inhibit T-lympho-
cyte signaling, while decreased lymphocyte proliferation
may be due to the impairment of glucose uptake by lym-
phocytes (Moriguchi et al, 1998). In diet-induced obese
animals (Table 1), similar results concerning the impairment
of the immune function have been found, although the
effects are less pronounced than in genetically obese
animals.
Tumor necrosis factor-alpha (TNF-a) is a common link
between obesity and insulin resistance=hyperinsulinemia. In
genetically obese animals, TNF-a production from adipose
tissue is reported to be higher (Samad et al, 1999), which may
influence lymphoid tissue development and induce pro-
grammed cell death (apoptosis). A chronic elevation of
Table 1 Immune-related indicators and UCP2 mRNA levels in diet-
induced (cafeteria) obese and control rats
Control Obese P
Food intake (g) 19.30.2 24.9 0.2 <0.01
Ratio CD4
þ
=CD8
þ
1.500.05 1.19 0.05 <0.05
LPS (cpm) 7882563 4140 251 <0.001
Con A (cpm) 10078563 9800 853 NS
PHA (cpm) 15488752 5646 430 <0.001
Phagocytosis (%) 78.022.11 83.37 1.54 NS
Oxidative burst (%) 75.524.47 61.93 2.89 <0.05
UCP2 mRNA 0.610.09 1.25 0.23 <0.05
Spleen lymphocytes T CD4þ and CD8þ, phagocytosis and oxidative burst
were analysed by flow cytometry. Lymphoproliferation was measured by [3H]-
thymidine method (LPS, 100 mg=ml; Con A, 5 mg=ml; PHA, 50 mg=ml). UCP2
mRNA levels were measured by semiquantitative RT-PCR. Phagocytosis and
oxidative burst were measured by flow cytometry. Data are expressed as
mean s.e.m., n¼ 9, NS, non statistically significant differences.
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TNF-a in obesity initiates a cascade of events (increased
production of PAI-1 and TGF-b) that may facilitate the
cardiovascular risk associated with this condition.
In obese Zucker rats, NK cell activity has been reported to
be suppressed, and the effect found to be reversible through
exercise training via improved lymphocyte glucose uptake
and enhanced GLUT-1 expression. On the other hand, pha-
gocytosis was not affected by obesity, but obese Zucker rats
had diminished ability to kill phagocytosed bacteria as
compared to control rats due to lower oxidative burst activ-
ity (Plotkin et al, 1996).
Poor oxidative burst activity was found in diet-induced
obese animals (Table 1), which is related to increased uncou-
pling protein-2 (UCP2) mRNA levels in spleen of obese rats.
Recently, a correlation (Arsenijevic et al, 2000) between the
expression of the UCP2 gene and reactive oxygen species
(ROS) production was reported. A mild uncoupling of
respiration by UCPs may regulate ROS production by
modulating proton leakage through the inner mitochondrial
membrane, suggesting a greater capacity of macrophages to
generate ROS with the absence of UCP2 in the mitochondria.
Other genes implicated in obesity, such as peroxisome pro-
liferator activated receptor (PPAR-g), which are highly
expressed in adipose tissue, seem to be a key modulator of
adipogenesis, but also appear to be involved in macrophage
and T-helper functions. Finally, leptin seems to be an acti-
vator of the immune system after starvation periods (Matar-
ese, 2000); however, central administration of leptin
stimulates CRH production which leads to urocortin secre-
tion producing T-lymphocyte inhibition. Moreover, it seems
that T-lymphocytes are able to produce urocortin so the role
of the leptin in the regulation of the immune response
remains unclear.
Obese individuals and immune function
Epidemiological data support the idea that obesity is asso-
ciated with alterations in immune function, but data are
controversial for some parameters (Samartı´n & Chandra,
2001). One of the problems in analyzing immune function
in obese individuals is that the effect of obesity itself on
immune system can be hidden by the coexistence of hyper-
glycemia and dyslipidemia. Studies in which obese indivi-
duals with diabetes, insulin resistance or hyperlipidemia are
excluded may eliminate these confounding factors. As
occurs in animal models, most investigations confirm a
lower capacity of lymphocytes to proliferate in response to
mitogen activation (Table 2). Insulin receptor synthesis on T-
lymphocytes after in vitro stimulation is reduced in obese
subjects (Nieman et al, 1999) and it is possible that this lower
expression may play a role in the impairment of T-lympho-
cyte functions.
Several studies showed that leukocyte and lymphocyte
subsets are elevated in obese individuals (Nieman et al,
1999). However, other investigations revealed a T-lympho-
penia in obese patients (Tanaka et al, 1993). This lymphope-
nia is apparently related to higher body mass index and in
vitro TNF-a production. It appears that obesity is related to a
reduced activity of natural killer cells in elderly men and
women. A negative correlation between body fat and natural
killer cell activity in elderly women and adult men has been
established (Nieman et al, 1999). In infants, a positive rela-
tionship between body weight and lower respiratory tract
infections has been observed. Possible reasons for the higher
incidence would include mechanical factors that affect pul-
monary functions and impaired immune status concerning
cell-mediated immunity and phagocyte function. Monocyte
and granulocyte phagocytosis were not influenced by obe-
sity, while basal and activated monocyte and basal granulo-
cyte oxidative bursts were higher in obese subjects.
Moreover, there are several studies that assess the immune
response in obese patients after weight loss or nutritional
deprivation, suggesting that immune impairments can be
corrected with adequate weight control (Table 2). Obese
patients after a moderate energy restriction have a lower
mitogen-stimulated proliferation response and decreased
monocyte oxidative burst as well as NK cell counts, but not
T- and B-cell counts (Nieman et al, 1996). While total
lymphocyte numbers did not change after a weight reduc-
tion program, the response of T-lymphocytes to different
mitogens was increased as well as B-lymphocyte blastogen-
esis at the end of the dietary restriction period (Tanaka et al,
2001). During the slimming period, fasting blood glucose
and serum triglyceride concentrations were slightly reduced.
Therefore, these results suggest that an improvement in the
physiological milieu may contribute to an improvement in
Table 2 Summary of the main immunological data in obese people
compared to lean individuals
Situation Outcome Reference
Obese individuals Higher total lymphocytes:
helper cells (CD4þ) and
cytotoxic T cells (CD8þ),
IL-6 and IL-1alpha levels and
C-reactive protein serum levels
Nieman et al (1999)
Visser et al (1999)
Raymond et al (1999)
Obese individuals Lower lymphocyte response
to mitogens related to TNF-a
higher levels
Nieman et al (1999)
Tanaka et al (1993)
Obese indivudals
after moderate
energy restriction
Lower proliferative responses
to mitogens
Nieman et al (1996)
Obese individuals
after weight
reduction
Increased T cell response and
higher proliferative
responses to mitogens
Tanaka et al
(1993 and 2001)
Obese individuals
after fasting
Lower PHA counts and higher
NK cell activity and IgM
Wing et al (1983)
Obese burn
individuals
Higher bacterinemia, sepsis,
duration of antibiotherapy
and stay at hospital
Gottschlich et al (1993)
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immune function during weight loss. A positive effect on
immune response might be observed over the long-term
period after subjects have achieved and maintained normal
weight. Further research is warranted in this area before
meaningful conclusions can be drawn because most of the
studies have analyzed the effects of short-term weight loss on
immunity in obese subjects. Moreover, the interactive effect
of changes in psychological stress with weight loss on
immune function need to be addressed. These results indi-
cate that nutritional restriction appears to enhance certain
effector functions of the host defense system in the obese
patient.
Final conclusions
In summary, obesity diminishes the immune response, but
the mechanisms implicated in this process remain unclear.
While, the excessive intake of dietary fat has an important
role in the responsiveness of immunocompetent cells and a
lower consumption is desirable, more research is needed to
understand the influence of dietary fat intake on immune
function. Data about the role of weight loss in the improve-
ment of immune response in obese patients are actually
confusing and further investigation is required. New
approaches are the immunomanipulation of the adipose
tissue with specific antibodies against adipocytes and dietary
patterns that potentiate the immune system.
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